Institutional investors purchased a net $14.4 million shares of IMMU during the quarter ended June 2019, and now own 83.16% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
POINT72 ASSET MANAGEMENT LP Bought 7.5 Million shares of Immunomedics Inc
AVORO CAPITAL ADVISOR LLC Bought 1.8 Million shares of Immunomedics Inc
ARCTIC FUND MANAGEMENT AS (SWEDE... Bought 76.0 Thousand shares of Immunomedics Inc